Home / Health / EU Weight-Loss Pill Review Concludes This Summer
EU Weight-Loss Pill Review Concludes This Summer
22 Apr
Summary
- European agency review of new weight-loss pills to conclude this summer.
- Regulatory review for first-generation weight-loss pills nearing completion.
- Pills have recently launched in the United States by major companies.
The European Medicines Agency (EMA) is nearing the completion of its regulatory review for a new class of weight-loss pills. Emer Cooke, the head of the EMA, announced at a recent event in Barcelona that the review process for the first of these next-generation medications would be concluded this summer.
Cooke indicated that the final decisions are expected 'very soon'. This development follows the recent market introductions of such pills in the United States by prominent pharmaceutical companies, including Denmark's Novo Nordisk and U.S. rival Eli Lilly. The EMA's upcoming conclusion is a significant step for these innovative treatments.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
